Nikko Asset Management Americas’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.8M Sell
1,830,203
-95,881
-5% -$1.25M 0.24% 71
2025
Q1
$20.4M Sell
1,926,084
-138,966
-7% -$1.47M 0.26% 64
2024
Q4
$34.9M Sell
2,065,050
-250,244
-11% -$4.23M 0.38% 52
2024
Q3
$53.7M Buy
2,315,294
+752,229
+48% +$17.4M 0.61% 42
2024
Q2
$38M Buy
1,563,065
+286,546
+22% +$6.96M 0.44% 48
2024
Q1
$43M Sell
1,276,519
-44,133
-3% -$1.49M 0.43% 52
2023
Q4
$41.6M Sell
1,320,652
-67,922
-5% -$2.14M 0.4% 50
2023
Q3
$35.4M Sell
1,388,574
-16,358
-1% -$417K 0.42% 51
2023
Q2
$40.3M Sell
1,404,932
-15,469
-1% -$443K 0.42% 50
2023
Q1
$33M Sell
1,420,401
-28,659
-2% -$665K 0.38% 44
2022
Q4
$24.6M Sell
1,449,060
-10,355
-0.7% -$176K 0.35% 51
2022
Q3
$21.2M Buy
1,459,415
+23,221
+2% +$337K 0.27% 64
2022
Q2
$18M Buy
1,436,194
+34,116
+2% +$426K 0.22% 67
2022
Q1
$37.9M Buy
1,402,078
+44,606
+3% +$1.2M 0.28% 67
2021
Q4
$47.8M Sell
1,357,472
-1,060
-0.1% -$37.3K 0.25% 71
2021
Q3
$62.5M Buy
1,358,532
+143,631
+12% +$6.61M 0.27% 70
2021
Q2
$41.2M Buy
1,214,901
+899,089
+285% +$30.5M 0.16% 82
2021
Q1
$13M Buy
315,812
+38,126
+14% +$1.57M 0.06% 124
2020
Q4
$12M Buy
277,686
+146,516
+112% +$6.36M 0.07% 123
2020
Q3
$5.63M Sell
131,170
-12,317
-9% -$528K 0.05% 133
2020
Q2
$6.56M Sell
143,487
-111,579
-44% -$5.1M 0.09% 98
2020
Q1
$3.47M Sell
255,066
-25,482
-9% -$346K 0.06% 113
2019
Q4
$3.05M Sell
280,548
-17,982
-6% -$195K 0.05% 141
2019
Q3
$3.07M Buy
298,530
+168,556
+130% +$1.73M 0.05% 139
2019
Q2
$1.23M Buy
129,974
+65,875
+103% +$622K 0.02% 154
2019
Q1
$438K Buy
+64,099
New +$438K 0.01% 156